1.10Open1.10Pre Close0 Volume47 Open Interest15.00Strike Price0.00Turnover159.83%IV12.43%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry1.10Extrinsic Value100Contract SizeAmericanOptions Type0.4731Delta0.1151Gamma13.02Leverage Ratio-0.0858Theta0.0013Rho6.16Eff Leverage0.0086Vega
Denali Therapeutics Stock Discussion
Clinical Trial Success: Denali's Hunter Syndrome Drug Delivers Game-Changing Patient Improvements
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$